Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer

Radiotherapy and Oncology

Volumn 102, Issue 1, 2012, Pages 115-121

  Hilbers, Florentine S M ^a   Boekel, Naomi B ^a   Van Den Broek, Alexandra J ^a   Van Hien, Richard ^b   Cornelissen, Sten ^b   Aleman, Berthe M P ^b   Van 'T Veer, Laura J ^b   Van Leeuwen, Flora E ^a   Schmidt, Marjanka K ^a,b  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Breast cancer; Radiation induced cardiovascular disease; TGFB 1

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEART; HUMAN; INTERNAL MAMMARY CHAIN IRRADIATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION EXPOSURE; RETROSPECTIVE STUDY;

AGED; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84455205571     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.10.017     Document Type: Article

References (48)

1. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 2000;355:1757-70.
2. J. Cuzick, H. Stewart, and L. Rutqvist Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy J Clin Oncol 12 1994 447 453
3. S.C. Darby, P. McGale, C.W. Taylor, and R. Peto Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries Lancet Oncol 6 2005 557 565
4. M.J. Hooning, B.M. Aleman, A.J. van Rosmalen, M.A. Kuenen, J.G. Klijn, and F.E. van Leeuwen Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study Int J Radiat Oncol Biol Phys 64 2006 1081 1091
5. L.E. Rutqvist, I. Lax, T. Fornander, and H. Johansson Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer Int J Radiat Oncol Biol Phys 22 1992 887 896
6. C.R. Correa, H.I. Litt, W.T. Hwang, V.A. Ferrari, L.J. Solin, and E.E. Harris Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer J Clin Oncol 25 2007 3031 3037
7. M.J. Hooning, A. Botma, and B.M. Aleman Long-term risk of cardiovascular disease in 10-year survivors of breast cancer J Natl Cancer Inst 99 2007 365 375
8. E.E. Harris, C. Correa, and W.T. Hwang Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment J Clin Oncol 24 2006 4100 4106
9. E.A. Lefrak, J. Pitha, S. Rosenheim, and J.A. Gottlieb A clinicopathologic analysis of adriamycin cardiotoxicity Cancer 32 1973 302 314
10. W. Rhoden, P. Hasleton, and N. Brooks Anthracyclines and the heart Br Heart J 70 1993 499 502
11. L.J. Steinherz, P.G. Steinherz, C.T. Tan, G. Heller, and M.L. Murphy Cardiac toxicity 4 to 20 years after completing anthracycline therapy JAMA 266 1991 1672 1677
12. B.M. Aleman, A.W. van den Belt-Dusebout, and M.L. De Bruin Late cardiotoxicity after treatment for Hodgkin lymphoma Blood 109 2007 1878 1886
13. S. Myrehaug, M. Pintilie, and R. Tsang Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy Leuk Lymphoma 49 2008 1486 1493
14. C.L. Shapiro, P.H. Hardenbergh, and R. Gelman Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients J Clin Oncol 16 1998 3493 3501
15. G.A. Tanteles, J. Whitworth, and J. Mills Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer? Br J Cancer 101 2009 403 409
16. C.N. Andreassen, J. Alsner, M. Overgaard, and J. Overgaard Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes Radiother Oncol 69 2003 127 135
17. C.N. Andreassen, J. Alsner, and J. Overgaard TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer Radiother Oncol 75 2005 18 21
18. S. Quarmby, H. Fakhoury, and E. Levine Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients Int J Radiat Biol 79 2003 137 143
19. M. Yokota, S. Ichihara, T.L. Lin, N. Nakashima, and Y. Yamada Association of a T29 → C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese Circulation 101 2000 2783 2787
20. M.S. Anscher, F.M. Kong, L.B. Marks, G.C. Bentel, and R.L. Jirtle Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis Int J Radiat Oncol Biol Phys 37 1997 253 258
21. K. Randall, and J.E. Coggle Expression of transforming growth factor-beta 1 in mouse skin during the acute phase of radiation damage Int J Radiat Biol 68 1995 301 309
22. M. Scharpfenecker, J.J. Kruse, D. Sprong, N.S. Russell, P. Ten Dijke, and F.A. Stewart Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells Int J Radiat Oncol Biol Phys 73 2009 506 513
23. L. Devy, S. Blacher, and C. Grignet-Debrus The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent FASEB J 16 2002 147 154
24. D.T. Eitzman, R.D. McCoy, and X. Zheng Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene J Clin Invest 97 1996 232 237
25. T. Oikawa, M. Freeman, W. Lo, D.E. Vaughan, and A. Fogo Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition Kidney Int 51 1997 164 172
26. L.P. Zhang, T. Takahara, and Y. Yata Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells J Hepatol 31 1999 703 711
27. S.J. Dawson, B. Wiman, A. Hamsten, F. Green, S. Humphries, and A.M. Henney The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells J Biol Chem 268 1993 10739 10745
28. P. Eriksson, B. Kallin, F.M. 't Hooft, P. Bavenholm, and A. Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc Natl Acad Sci USA 92 1995 1851 1855
29. Z. Ye, E.H. Liu, and J.P. Higgins Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66, 155 cases and 91, 307 controls Lancet 367 2006 651 658
30. M.K. Schmidt, R.A. Tollenaar, and S.R. de Kemp Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK21100delC germline mutation J Clin Oncol 25 2007 64 69
31. S.M. Bentzen Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology Nat Rev Cancer 6 2006 702 713
32. A. Leask, and D.J. Abraham TGF-beta signaling and the fibrotic response FASEB J 18 2004 816 827
33. S.C. Darby, D.J. Cutter, and M. Boerma Radiation-related heart disease: current knowledge and future prospects Int J Radiat Oncol Biol Phys 76 2010 656 665
34. G.C. Barnett, C.E. Coles, and N.G. Burnet No association between SNPs regulating TGF-beta1 secretion and late radiotherapy toxicity to the breast: Results from the RAPPER study Radiother Oncol 2010
35. C.N. Andreassen Searching for genetic determinants of normal tissue radiosensitivity-are we on the right track? Radiother Oncol 97 2010 1 8
36. M.S. Pepper Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity Cytokine Growth Factor Rev 8 1997 21 43
37. W. Koch, P. Hoppmann, J.C. Mueller, A. Schomig, and A. Kastrati Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease Arterioscler Thromb Vasc Biol 26 2006 1114 1119
38. S. Darby, P. McGale, R. Peto, F. Granath, P. Hall, and A. Ekbom Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90,000 Swedish women BMJ 326 2003 256 257
39. R. Jagsi, K.A. Griffith, T. Koelling, R. Roberts, and L.J. Pierce Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer Cancer 109 2007 650 657
40. L.F. Paszat, W.J. Mackillop, P.A. Groome, K. Schulze, and E. Holowaty Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada Int J Radiat Oncol Biol Phys 43 1999 755 762
41. P. McGale, S.C. Darby, and P. Hall Incidence of heart disease in 35, 000 women treated with radiotherapy for breast cancer in Denmark and Sweden Radiother Oncol 100 2011 167 175
42. I. Hojris, M. Overgaard, J.J. Christensen, and J. Overgaard Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group Lancet 354 1999 1425 1430
43. A.J. Nixon, J. Manola, and R. Gelman No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques J Clin Oncol 16 1998 1374 1379
44. L.E. Rutqvist, A. Liedberg, N. Hammar, and K. Dalberg Myocardial infarction among women with early-stage breast cancer treated with conservative surgery and breast irradiation Int J Radiat Oncol Biol Phys 40 1998 359 363
45. K.A. Vallis, M. Pintilie, and N. Chong Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer J Clin Oncol 20 2002 1036 1042
46. S. Lettmaier, S. Kreppner, and M. Lotter Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: A dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy Radiother Oncol 100 2011 189 194
47. C.W. Taylor, A. Nisbet, P. McGale, and S.C. Darby Cardiac exposures in breast cancer radiotherapy: 1950s-1990s Int J Radiat Oncol Biol Phys 69 2007 1484 1495
48. J.H. Borger, M.J. Hooning, and L.J. Boersma Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume Int J Radiat Oncol Biol Phys 69 2007 1131 1138